Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 36Neoplasms 32Prostatic Neoplasms 26Colorectal Neoplasms 25Lung Neoplasms 21Carcinoma, Non-Small-Cell Lung 16Hematologic Neoplasms 13Neoplasm Metastasis 10Pancreatic Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Head and Neck Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Hematopoietic and Lymphatic System Neoplasm 7Stomach Neoplasms 6Carcinoma, Renal Cell 6Anatomic Stage I Breast Cancer AJCC v8 6Uterine Cervical Neoplasms 5Sarcoma 5Glioma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Gastrointestinal Neoplasms 4

Interventions

Standard of Care 2Sodium Chloride 2Radiotherapy 2epigallocatechin gallate 1Triamcinolone Acetonide 1Thioctic Acid 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Radiodermatitis × Standard of Care × 1 year × Clear all
NCT07081074 2026-04-15

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

West China Hospital

Phase NA Recruiting
40 enrolled

Radiodermatitis

NCT07064577 2025-08-07

Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

West China Hospital

Phase NA Recruiting
30 enrolled

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡